Home
About
Overview
Sharing Data
ORCID
Help
History (1)
A Phase I study of raltitrexed and paclitaxel given every 3 weeks to patients with solid tumors.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
A Phase I study of raltitrexed and paclitaxel given every 3 weeks to patients with solid tumors.
A Phase I study of raltitrexed and paclitaxel given every 3 weeks to patients with solid tumors. Cancer. 1999 Aug 01; 86(3):528-32.
View in:
PubMed
subject areas
Adult
Aged
Aged, 80 and over
Antineoplastic Combined Chemotherapy Protocols
Cohort Studies
Drug Administration Schedule
Drug Evaluation
Female
Humans
Lymphoma
Male
Middle Aged
Neoplasms
Neutropenia
Paclitaxel
Quinazolines
Thiophenes
authors with profiles
Mark J. Ratain